Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mortality in Pulmonary Arterial Hypertension in the Modern Era: Early Insights From the Pulmonary Hypertension Association Registry
Kevin Y. Chang, Sue Duval, David B. Badesch, et al.
Journal of the American Heart Association (2022) Vol. 11, Iss. 9
Open Access | Times Cited: 122

Showing 1-25 of 122 citing articles:

2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association
Seth S. Martin, Aaron W. Aday, Zaid Almarzooq, et al.
Circulation (2024) Vol. 149, Iss. 8
Open Access | Times Cited: 934
Pathophysiology and new advances in pulmonary hypertension
Simon Bousseau, Rafael Sobrano Fais, Sue Gu, et al.
BMJ Medicine (2023) Vol. 2, Iss. 1, pp. e000137-e000137
Open Access | Times Cited: 50
Cardiovascular–obstetric state-of-the-art review: pulmonary hypertension in pregnancy
Jia Hui Joey Ong, Jeannie Jing Yi Yap, Mahesh Choolani, et al.
Singapore Medical Journal (2025) Vol. 66, Iss. 3, pp. 130-140
Open Access | Times Cited: 2
Salidroside protects pulmonary artery endothelial cells against hypoxia-induced apoptosis via the AhR/NF-κB and Nrf2/HO-1 pathways
Wei Lei, Meihong Chen, Zu-feng Huang, et al.
Phytomedicine (2024) Vol. 128, pp. 155376-155376
Open Access | Times Cited: 10
Obstructive Sleep Apnea, Obesity Hypoventilation Syndrome, and Pulmonary Hypertension
Sarah Bjork, Deepanjali Jain, Manuel Hache Marliere, et al.
Sleep Medicine Clinics (2024) Vol. 19, Iss. 2, pp. 307-325
Closed Access | Times Cited: 10
Contemporary Treatment of Pulmonary Arterial Hypertension: A US Perspective
Sandeep Sahay, Murali M. Chakinala, Nick H. Kim, et al.
American Journal of Respiratory and Critical Care Medicine (2024) Vol. 210, Iss. 5, pp. 581-592
Closed Access | Times Cited: 10
Ultrasound Neuromodulation of an Anti-Inflammatory Pathway at the Spleen Improves Experimental Pulmonary Hypertension
Stefanos Zafeiropoulos, Umair Ahmed, Αlexandra Bekiaridou, et al.
Circulation Research (2024) Vol. 135, Iss. 1, pp. 41-56
Closed Access | Times Cited: 9
Vasoreactive testing prevalence and characteristics in patients with idiopathic pulmonary arterial hypertension
Garcia Perez Rosa Natalia, Kirill Lapshin, А. В. Березина, et al.
Annals of Thoracic Medicine (2025) Vol. 20, Iss. 1, pp. 62-70
Open Access | Times Cited: 1
Sex-dependent pathophysiology and therapeutic considerations in right heart disease
Sue Gu, Benjamin J. Kopecky, Brisa Peña, et al.
Canadian Journal of Cardiology (2025)
Closed Access | Times Cited: 1
Pericytes: The lung-forgotten cell type
Annelise T. Garrison, R.E. Bignold, Xinhui Wu, et al.
Frontiers in Physiology (2023) Vol. 14
Open Access | Times Cited: 18
Evidence of Hyperglycemic Levels Improving the Binding Capacity between Human Serum Albumin and the Antihypertensive Drug Hydrochlorothiazide
Marília Amável Gomes Soares, Franklin Souza‐Silva, Carlos Roberto Alves, et al.
Scientia Pharmaceutica (2024) Vol. 92, Iss. 2, pp. 32-32
Open Access | Times Cited: 7
The evolution of survival of pulmonary arterial hypertension over 15 years
Paul M. Hendriks, Diederik P. Staal, Liza D. van de Groep, et al.
Pulmonary Circulation (2022) Vol. 12, Iss. 4
Open Access | Times Cited: 27
Real-World Management of Patients with Pulmonary Arterial Hypertension: Insights from EXPOSURE
Audrey Muller, Pilar Escribano Subías, Catarina Fernandes, et al.
Advances in Therapy (2024) Vol. 41, Iss. 3, pp. 1103-1119
Open Access | Times Cited: 6
Survival analysis from the INCREASE study in PH-ILD: evaluating the impact of treatment crossover on overall mortality
Steven D. Nathan, Shilpa Johri, Joanna M. Joly, et al.
Thorax (2023), pp. thorax-220821
Open Access | Times Cited: 13
European Society of Cardiology quality indicators for the care and outcomes of adults with pulmonary arterial hypertension. Developed in collaboration with the Heart Failure Association of the European Society of Cardiology
Suleman Aktaa, Chris P Gale, Margarita Brida, et al.
European Journal of Heart Failure (2023) Vol. 25, Iss. 4, pp. 469-477
Open Access | Times Cited: 11
CS1, a controlled‐release formulation of valproic acid, for the treatment of patients with pulmonary arterial hypertension: Rationale and design of a Phase 2 clinical trial
Raymond L. Benza, Philip B. Adamson, Deepak L. Bhatt, et al.
Pulmonary Circulation (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Comparison Between REVEAL Lite 2 and COMPERA 2.0 for Risk Stratification in Pulmonary Arterial Hypertension
Sandeep Sahay, Nelson Villasmil, Fredrick Wang, et al.
CHEST Journal (2024) Vol. 166, Iss. 2, pp. 373-387
Closed Access | Times Cited: 4
Neutrophil extracellular traps promote proliferation of pulmonary smooth muscle cells mediated by CCDC25 in pulmonary arterial hypertension
Hongxiao Sun, Zhanhui Du, Xu Zhang, et al.
Respiratory Research (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 4
Safety and efficacy of rodatristat ethyl for the treatment of pulmonary arterial hypertension (ELEVATE-2): a dose-ranging, randomised, multicentre, phase 2b trial
Olivier Sitbon, Andris Skride, Jeremy Feldman, et al.
The Lancet Respiratory Medicine (2024)
Closed Access | Times Cited: 4
Survival, morbidity, and quality of life in pulmonary arterial hypertension patients: a systematic review of outcomes reported by population-based observational studies
Stefan Reinders, Eva‐Maria Didden, Rose Ong
Respiratory Research (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 4
Endothelial FUNDC1 Deficiency Drives Pulmonary Hypertension
Yandong Pei, Dongfeng Ren, Yibing Yin, et al.
Circulation Research (2024) Vol. 136, Iss. 2
Closed Access | Times Cited: 4
Approach to Lung Transplantation in Pulmonary Arterial Hypertension: A Delphi Consensus on Behalf of the Transplant Task Force of the Pulmonary Vascular Research Institute
Nicholas A. Kolaitis, Hayley Barnes, Deborah J. Levine, et al.
Pulmonary Circulation (2025) Vol. 15, Iss. 2
Open Access
Association of Pulmonary Artery Radiation with Pulmonary Hypertension after Lung Cancer Radiotherapy
Katelyn M. Atkins, Samuel C. Zhang, Christopher E. Kehayias, et al.
(2025)
Closed Access
A new day has come: Sotatercept for the treatment of pulmonary arterial hypertension
Thomas Cascino, Sandeep Sahay, Victor Moles, et al.
The Journal of Heart and Lung Transplantation (2024)
Closed Access | Times Cited: 3
Disparities in Clinical Outcomes Observed Within Electronic Health Record Data From a Statewide Cohort of Pulmonary Arterial Hypertension Patients
Rachel Dalton, Ankit A. Desai, Tianze Jiao, et al.
Pulmonary Circulation (2025) Vol. 15, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top